Notably, most reported cases of colony-stimulating factor-producing lung malignancies are histologically classified as LCLC, with colony-stimulating factor hypothesized to potentiate tumor proliferation and metastatic competence. The gene discussed is CSF2; the disease is lung large cell carcinoma.